Literature DB >> 18945253

Perinatal risk factors and coeliac disease in children and young adults: a record linkage study.

S E Roberts1, J G Williams, D Meddings, R Davidson, M J Goldacre.   

Abstract

BACKGROUND: Little is known about perinatal risk factors and coeliac disease. AIM: To investigate the relationship between perinatal risk factors and subsequent coeliac disease among offspring.
METHODS: Record linked abstracts of birth registrations, maternity, in-patient and day case records in a defined population of southern England.
RESULTS: Using univariate analysis, coeliac disease in the child was associated with maternal coeliac disease (odds ratio = 20.6; 95% CI = 5.04-84.0; based on two cases in both mother and child) and with social class, year of birth, maternal smoking and parity. Multivariate analysis confirmed an increased risk of coeliac disease of 3.79 (95% CI = 1.85-7.79) for classes IV and V compared with I and II, an increased risk of 1.92 (1.06-3.49) for births during 1975-1979 compared with 1970-1974 and an increased risk of 1.80 (1.05-3.09) for 'subsequent' compared with 'first' births. Smoking during pregnancy was no longer associated with coeliac disease. Because numbers were small, maternal coeliac disease was excluded from the multivariate analysis.
CONCLUSIONS: This study shows increased risks of coeliac disease for manual social classes, births during the late 1970s and 'subsequent' births. Overall, perinatal risk factors seem to have a limited role in the aetiology of coeliac disease in children and young adults.

Entities:  

Mesh:

Year:  2008        PMID: 18945253     DOI: 10.1111/j.1365-2036.2008.03871.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  24 in total

1.  Hospital episode statistics: time for radical change.

Authors:  J G Williams; I Carpenter
Journal:  Clin Med (Lond)       Date:  2012-02       Impact factor: 2.659

2.  Monitoring clinical activity and performance: how can hospital episode statistics be made fit for purpose?

Authors:  John G Williams
Journal:  Frontline Gastroenterol       Date:  2011-03-31

Review 3.  Support for patients with celiac disease: A literature review.

Authors:  Jonas F Ludvigsson; Tim Card; Paul J Ciclitira; Gillian L Swift; Ikram Nasr; David S Sanders; Carolina Ciacci
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

4.  Perinatal risk factors for development of celiac disease in children, based on the prospective Norwegian Mother and Child Cohort Study.

Authors:  Louise Emilsson; Maria Christine Magnus; Ketil Størdal
Journal:  Clin Gastroenterol Hepatol       Date:  2014-10-18       Impact factor: 11.382

5.  Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study.

Authors:  Karl Mårild; Olof Stephansson; Scott Montgomery; Joseph A Murray; Jonas F Ludvigsson
Journal:  Gastroenterology       Date:  2011-10-10       Impact factor: 22.682

6.  Perinatal and early life risk factors for inflammatory bowel disease.

Authors:  Stephen E Roberts; Clare J Wotton; John G Williams; Myfanwy Griffith; Michael J Goldacre
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

Review 7.  The global burden of coeliac disease: opportunities and challenges.

Authors:  Govind K Makharia; Prashant Singh; Carlo Catassi; David S Sanders; Daniel Leffler; Raja Affendi Raja Ali; Julio C Bai
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-01-03       Impact factor: 46.802

Review 8.  Pathophysiology of celiac disease.

Authors:  Sonia S Kupfer; Bana Jabri
Journal:  Gastrointest Endosc Clin N Am       Date:  2012-08-30

Review 9.  Checkpoint Inhibitors and Induction of Celiac Disease-like Condition.

Authors:  Aaron Lerner; Carina Benzvi
Journal:  Biomedicines       Date:  2022-03-04

10.  Early infections are associated with increased risk for celiac disease: an incident case-referent study.

Authors:  Anna Myléus; Olle Hernell; Leif Gothefors; Marie-Louise Hammarström; Lars-Åke Persson; Hans Stenlund; Anneli Ivarsson
Journal:  BMC Pediatr       Date:  2012-12-19       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.